Clinical trial Recruiting at 1 site Interventional Ages 60 and up

CBT-I for insomnia in older African American adults

Official title: Cognitive Behavioral Therapy for Insomnia in Older African American Adults

Run by Rutgers, The State University of New Jersey · NCT06791356 · Data updated 2026-11-12

This project will try an eight-session online CBT-I program to see if it helps older African American adults who have chronic insomnia.

More Older Adults (65 Years and Older) trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment20 (estimated)
SponsorRutgers, The State University of New Jersey
Academic / other
Locations1 site (Newark, New Jersey)
StatusRecruiting
StartedJune 2, 2025
Main results expectedJune 2026
Study endsJune 2027
Registry record updatedFebruary 20, 2026
Trial IDNCT06791356 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking African American adults age 60+ enrolled in the Pathways to Healthy Aging study with at least three months of insomnia, PSQI component scores >2 as specified, and MoCA scores of 20–26 who can attend Rutgers for assessments and join eight Zoom sessions.

Probably not a fit

People taking certain regular sedative or sleep-altering medications, those with MoCA scores below 20, those not enrolled in the Pathways cohort, or those unable to use Zoom or travel to Rutgers for assessments are unlikely to be eligible or benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot interventional study will test the feasibility and preliminary effects of cognitive-behavioral therapy for insomnia (CBT-I) delivered in eight sessions via Zoom, compared with sleep hygiene education, among older African American participants drawn from the Pathways to Healthy Aging cohort. Participants must be age 60 or older, self-identify as African American or Black, have chronic insomnia for at least three months, meet brief sleep disturbance thresholds on the PSQI-derived components, and have a MoCA score between 20 and 26. The protocol includes pre- and post-intervention assessment visits at Rutgers University (Newark, NJ) and remote therapy sessions, with medication and cognitive-screening exclusions to reduce confounding. As a feasibility pilot, the study will generate preliminary outcome data to inform larger trials focused on this underrepresented population.

Why it matters

Potential benefit: If successful, the program could improve sleep quality and reduce insomnia symptoms long-term without relying on sleep medications.

How similar studies have gone: CBT-I has shown consistent benefits for adults and older adults with insomnia in prior studies, but targeted evidence in older African American populations is limited, making this application relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Reading level 6th grade or better and can speak and understand English well.
* Self-identify as African American or Black.
* Ages 60 and over.
* Score of \>2 in PSQI sleep duration, sleep disturbance, or overall sleep quality calculated components.
* Participating in the "Pathways to Healthy Aging in African Americans" study.
* Has established chronic insomnia issues for at least three months.
* Subjects must be willing to participate in 8 sessions of CBT-I via Zoom for the CBT-I group.
* Subjects must be willing to come for pre/post assessment visits.
* MoCA score of between 20-26.

Exclusion Criteria:

* Currently taking any of the following medications consistently: Benzodiazepines (ProSom, Restoril, Ativan and Xanax); Z Drugs (eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist); antidepressants that affect sleep (doxepin, mirtazapine, trazodone); antihistamines (diphenhydramine and doxylamine succinate); barbiturates (methohexital, pentobarbital, primidone, secobarbital).
* Diagnosed with any sleep disorder other than insomnia (i.e. obstructive sleep apnea using STOP-BANG, restless leg syndrome, REM sleep behavior disorder, etc.).
* Classified as high fall risk.
* Primary causes for frequent awakenings are due to a medical condition that is not related to insomnia, such as chronic pain, urinary frequency, upper respiratory infection.
* Previous experience with CBT-I.

Where it's running

  • Rutgers University
    Newark, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.